Session Track · IDC 2027

Basal Cell Carcinoma at IDC 2027

Part of the IDC 2027 scientific program · NH Villa Carpegna, Rome, Italy · June 21–23, 2027

About the Basal Cell Carcinoma Session

Basal Cell Carcinoma (BCC) is the most common form of skin cancer, primarily affecting fair-skinned individuals. Originating from the basal cells in the epidermis, it often presents as a small, pearly bump or a flat, scaly patch. While BCC is typically slow-growing and rarely metastasizes, it can cause significant local damage if left untreated. Risk factors include prolonged sun exposure, a history of sunburns, and certain genetic conditions. Dermatological treatments often involve surgical excision, Mohs surgery, or topical therapies, which aim to remove the cancerous cells while preserving surrounding skin. In cosmetology, early detection and treatment can help maintain skin integrity and aesthetics, making regular skin checks essential for prevention. Sun protection measures, such as using broad-spectrum sunscreen and wearing protective clothing, are crucial in reducing the risk of BCC.

Featured Speakers — Basal Cell Carcinoma 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Basal Cell Carcinoma Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at IDC 2027

Why Attend the Basal Cell Carcinoma Conference 2027

Present Your Research

Oral and poster slots for original Basal Cell Carcinoma work, reviewed by the scientific committee.

Network Globally

Meet researchers, clinicians, and industry leaders from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Basal Cell Carcinoma research and practice.

Hybrid Flexibility

Attend in person in Rome or join virtually — same program, same certificate.

Join IDC 2027 for the Basal Cell Carcinoma track

Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.

Basal Cell Carcinoma Conference 2027 — FAQs

What is the Basal Cell Carcinoma track at IDC 2027?

The Basal Cell Carcinoma track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Basal Cell Carcinoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Basal Cell Carcinoma sessions?

Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Basal Cell Carcinoma are all welcome — whether presenting or attending.

Can I present my research in the Basal Cell Carcinoma track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Basal Cell Carcinoma sessions?

Yes. IDC 2027 is a hybrid conference — attend the Basal Cell Carcinoma track in person in Rome or join live online, with on-demand access afterward.

Join the IDC 2027 delegation

Rome · June 21–23, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.